Cognition Therapeutics Inc
CGTX· Nasdaq
Released Aug 9, 2022, before the open
10-Q filed Aug 9, 2022, 40 days after period end · 0001558370-22-012749
| Metric | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|
| Net Income | -$5.75M | -$1.49M | -$1.67M |
| EPS Diluted | -$0.25 | -$4.77 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cognition Therapeutics Inc · CIK 1455365 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Jun 30, 2022 · filed Aug 9, 2022 · 40 d after period end
4.7% from the close of Aug 8, 2022 to the close of Aug 9, 2022, the first after the release.